Back to search
Metastatic Castration-Resistant Prostate Cancer Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Castration-Resistant Prostate Cancer Patients trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Castration-Resistant Prostate Cancer Patients trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to determine how well the study drug XL092 is helping to treat a participant's cancer after 16 weeks of treatment. Researchers will…
This phase I/II trial tests the safety and effectiveness of cell therapy (STEAP1 CART) with enzalutamide in treating patients with prostate cancer that continue…
Assessment of the safety and efficacy of HLD-0915 in patients with metastatic prostate cancer who have progressed on prior systemic therapies, with further eval…
The purpose of this study is to find out whether tinengotinib in combination with abiraterone acetate and prednisone or enzalutamide is a safe treatment that ca…
The main purpose of this study is to determine the safety, tolerability (how the body reacts to the drug\[s\]) and effectiveness (ability to treat the cancer) o…
This is an observational study in which participants receive a treatment which is already available for doctors to prescribe for non-metastatic castration-resis…
The study will generate regionally relevant data to inform clinical practice, support treatment guidelines, and potentially contribute to supportive evidence fo…
This is an open-label, phase 1b dose-escalation study of cabozantinib in combination with 177Lu-PSMA-617 in subjects with mCRPC. The primary hypothesis is that…